Rare Disease Trial, Recruiting NCT07008612 Sponsor: University Hospital, Rouen Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT07008612
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the MYT1L Group:

  • You must be at least 6 years old (there is no upper age limit)
  • You must speak French
  • If the patient is a child, a parent or legal guardian must give their consent to participate
  • You must have French health/social security coverage

For the Prosody Comparison Group:

  • Vision or hearing problems that cannot be corrected with glasses or hearing aids, making testing impossible (confirm with trial site)
  • Patients who do not speak French
  • Patients who have two separate genetic diagnoses, both affecting brain development (confirm with trial site)
  • Patients with a neurological condition caused by an outside event (such as a brain injury), rather than a genetic condition

Who may not be able to join:

For the MYT1L Group:

  • People who have vision or hearing problems that cannot be corrected, making it impossible to complete the assessments
  • People who do not speak French
  • People who have two separate genetic diagnoses that both affect brain development (confirm with trial site)
  • People whose neurological condition was caused by an outside event rather than genetics

For the Prosody Comparison Group:

  • People who have a confirmed diagnosis of MYT1L syndrome
  • People who are unable to communicate verbally (non-speaking patients)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 32 88 82 65

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Rouen
Registry
ClinicalTrials.gov
Start date
4 February 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Speech-language profile

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov